nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—VEGFA—glaucoma	0.562	1	CbGaD
Gliclazide—CYP2C19—Methazolamide—glaucoma	0.0339	0.218	CbGbCtD
Gliclazide—CYP2C9—Diclofenamide—glaucoma	0.0327	0.211	CbGbCtD
Gliclazide—CYP2C9—Dorzolamide—glaucoma	0.0316	0.204	CbGbCtD
Gliclazide—CYP2C19—Timolol—glaucoma	0.0288	0.186	CbGbCtD
Gliclazide—CYP2C9—Methazolamide—glaucoma	0.0282	0.182	CbGbCtD
Gliclazide—VEGFA—Timolol—Levobunolol—glaucoma	0.00315	0.65	CbGdCrCtD
Gliclazide—Glyburide—ABCA1—glaucoma	0.00141	1	CrCbGaD
Gliclazide—VEGFA—Pindolol—Levobunolol—glaucoma	0.000468	0.0967	CbGdCrCtD
Gliclazide—VEGFA—Pindolol—Carteolol—glaucoma	0.000468	0.0967	CbGdCrCtD
Gliclazide—VEGFA—Pindolol—Metipranolol—glaucoma	0.000447	0.0922	CbGdCrCtD
Gliclazide—VEGFA—Pindolol—Betaxolol—glaucoma	0.000312	0.0645	CbGdCrCtD
Gliclazide—ABCC8—Neuronal System—SLC6A1—glaucoma	0.000215	0.00338	CbGpPWpGaD
Gliclazide—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	0.000214	0.00336	CbGpPWpGaD
Gliclazide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000212	0.00333	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—TP53—glaucoma	0.000212	0.00333	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—SLC6A1—glaucoma	0.000209	0.00328	CbGpPWpGaD
Gliclazide—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—glaucoma	0.000208	0.00326	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—TXN—glaucoma	0.000196	0.00308	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CA5A—glaucoma	0.000193	0.00304	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—NARFL—glaucoma	0.000193	0.00304	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.000193	0.00303	CbGpPWpGaD
Gliclazide—VEGFA—Integrins in angiogenesis—CDKN1B—glaucoma	0.000191	0.00301	CbGpPWpGaD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—CAV1—glaucoma	0.000191	0.003	CbGpPWpGaD
Gliclazide—ALB—Lipid and lipoprotein metabolism—ABCA1—glaucoma	0.00019	0.00299	CbGpPWpGaD
Gliclazide—ALB—Lipoprotein metabolism—APOE—glaucoma	0.000188	0.00296	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—NARFL—glaucoma	0.000187	0.00294	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CA5A—glaucoma	0.000187	0.00294	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—ABCA1—glaucoma	0.000187	0.00294	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—CDKN1B—glaucoma	0.000187	0.00293	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000182	0.00285	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—CAV1—glaucoma	0.00018	0.00284	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000175	0.00276	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—MMP9—glaucoma	0.000175	0.00275	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000174	0.00274	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—CCND2—glaucoma	0.000174	0.00274	CbGpPWpGaD
Gliclazide—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	0.000174	0.00273	CbGpPWpGaD
Gliclazide—VEGFA—EPH-Ephrin signaling—MMP2—glaucoma	0.000171	0.00269	CbGpPWpGaD
Gliclazide—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000171	0.00268	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000169	0.00265	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—SOD1—glaucoma	0.000167	0.00262	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—NGF—glaucoma	0.000161	0.00253	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.00016	0.00252	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—NCK2—glaucoma	0.000159	0.0025	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000158	0.00248	CbGpPWpGaD
Gliclazide—ALB—FOXA2 and FOXA3 transcription factor networks—NR3C1—glaucoma	0.000156	0.00245	CbGpPWpGaD
Gliclazide—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000156	0.00245	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000156	0.00244	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000155	0.00243	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—TGFB2—glaucoma	0.000154	0.00241	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—ABCA1—glaucoma	0.000152	0.00239	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000151	0.00238	CbGpPWpGaD
Gliclazide—ALB—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.00015	0.00236	CbGpPWpGaD
Gliclazide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000148	0.00232	CbGpPWpGaD
Gliclazide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—glaucoma	0.000147	0.0023	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—glaucoma	0.000146	0.0023	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—SOD1—glaucoma	0.000146	0.0023	CbGpPWpGaD
Gliclazide—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000146	0.00229	CbGpPWpGaD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—NOS3—glaucoma	0.000145	0.00227	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000136	0.00214	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—NOS3—glaucoma	0.000136	0.00214	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—SOD1—glaucoma	0.000136	0.00213	CbGpPWpGaD
Gliclazide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000135	0.00211	CbGpPWpGaD
Gliclazide—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000133	0.00209	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—MTHFR—glaucoma	0.000132	0.00208	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000132	0.00208	CbGpPWpGaD
Gliclazide—VEGFA—EPH-Ephrin signaling—MMP9—glaucoma	0.000129	0.00202	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—SOD1—glaucoma	0.000127	0.00199	CbGpPWpGaD
Gliclazide—ALB—Lipid and lipoprotein metabolism—APOE—glaucoma	0.000125	0.00197	CbGpPWpGaD
Gliclazide—ALB—Lipid and lipoprotein metabolism—CAV1—glaucoma	0.000124	0.00195	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—APOE—glaucoma	0.000123	0.00194	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—ABCA1—glaucoma	0.000121	0.0019	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—CAV1—glaucoma	0.000121	0.0019	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—CDKN2B—glaucoma	0.00012	0.00189	CbGpPWpGaD
Gliclazide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00012	0.00188	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—TP53—glaucoma	0.000117	0.00184	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—SOD1—glaucoma	0.000116	0.00183	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000116	0.00182	CbGpPWpGaD
Gliclazide—Pain—Dorzolamide—glaucoma	0.000115	0.000542	CcSEcCtD
Gliclazide—Insomnia—Pilocarpine—glaucoma	0.000115	0.000542	CcSEcCtD
Gliclazide—VEGFA—Focal Adhesion—FN1—glaucoma	0.000115	0.00181	CbGpPWpGaD
Gliclazide—Constipation—Travoprost—glaucoma	0.000115	0.00054	CcSEcCtD
Gliclazide—Pain—Travoprost—glaucoma	0.000115	0.00054	CcSEcCtD
Gliclazide—Hyperglycaemia—Timolol—glaucoma	0.000115	0.00054	CcSEcCtD
Gliclazide—Agitation—Clonidine—glaucoma	0.000115	0.000539	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000115	0.000538	CcSEcCtD
Gliclazide—VEGFA—Cellular responses to stress—IL1A—glaucoma	0.000115	0.0018	CbGpPWpGaD
Gliclazide—Paraesthesia—Pilocarpine—glaucoma	0.000115	0.000538	CcSEcCtD
Gliclazide—Asthenia—Bimatoprost—glaucoma	0.000115	0.000538	CcSEcCtD
Gliclazide—Fatigue—Brinzolamide—glaucoma	0.000114	0.000537	CcSEcCtD
Gliclazide—Angioedema—Clonidine—glaucoma	0.000114	0.000536	CcSEcCtD
Gliclazide—VEGFA—Allograft Rejection—TNF—glaucoma	0.000114	0.00179	CbGpPWpGaD
Gliclazide—Dyspnoea—Pilocarpine—glaucoma	0.000114	0.000534	CcSEcCtD
Gliclazide—VEGFA—Focal Adhesion—BAD—glaucoma	0.000114	0.00178	CbGpPWpGaD
Gliclazide—Pain—Brinzolamide—glaucoma	0.000113	0.000533	CcSEcCtD
Gliclazide—Somnolence—Pilocarpine—glaucoma	0.000113	0.000532	CcSEcCtD
Gliclazide—Depression—Timolol—glaucoma	0.000113	0.000532	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000113	0.00178	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—PEX19—glaucoma	0.000113	0.00178	CbGpPWpGaD
Gliclazide—Pruritus—Bimatoprost—glaucoma	0.000113	0.00053	CcSEcCtD
Gliclazide—Diarrhoea—Apraclonidine—glaucoma	0.000113	0.000529	CcSEcCtD
Gliclazide—Malaise—Clonidine—glaucoma	0.000113	0.000529	CcSEcCtD
Gliclazide—Dyspepsia—Pilocarpine—glaucoma	0.000112	0.000527	CcSEcCtD
Gliclazide—Chills—Betaxolol—glaucoma	0.000112	0.000526	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—LRP12—glaucoma	0.000112	0.00176	CbGpPWpGaD
Gliclazide—Arrhythmia—Betaxolol—glaucoma	0.000111	0.000524	CcSEcCtD
Gliclazide—Feeling abnormal—Dorzolamide—glaucoma	0.000111	0.000522	CcSEcCtD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—glaucoma	0.000111	0.00174	CbGpPWpGaD
Gliclazide—Feeling abnormal—Travoprost—glaucoma	0.000111	0.00052	CcSEcCtD
Gliclazide—Conjunctivitis—Timolol—glaucoma	0.00011	0.000518	CcSEcCtD
Gliclazide—Gastrointestinal pain—Dorzolamide—glaucoma	0.00011	0.000518	CcSEcCtD
Gliclazide—Palpitations—Clonidine—glaucoma	0.00011	0.000518	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00011	0.000517	CcSEcCtD
Gliclazide—Gastrointestinal pain—Travoprost—glaucoma	0.00011	0.000516	CcSEcCtD
Gliclazide—Loss of consciousness—Clonidine—glaucoma	0.00011	0.000515	CcSEcCtD
Gliclazide—Feeling abnormal—Brinzolamide—glaucoma	0.000109	0.000514	CcSEcCtD
Gliclazide—Mental disorder—Betaxolol—glaucoma	0.000109	0.000514	CcSEcCtD
Gliclazide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000109	0.00171	CbGpPWpGaD
Gliclazide—Pain—Pilocarpine—glaucoma	0.000109	0.000512	CcSEcCtD
Gliclazide—Constipation—Pilocarpine—glaucoma	0.000109	0.000512	CcSEcCtD
Gliclazide—Cough—Clonidine—glaucoma	0.000109	0.000511	CcSEcCtD
Gliclazide—Sweating—Timolol—glaucoma	0.000109	0.000511	CcSEcCtD
Gliclazide—Dizziness—Apraclonidine—glaucoma	0.000109	0.000511	CcSEcCtD
Gliclazide—Malnutrition—Betaxolol—glaucoma	0.000109	0.00051	CcSEcCtD
Gliclazide—Erythema—Betaxolol—glaucoma	0.000109	0.00051	CcSEcCtD
Gliclazide—ALB—Selenium Micronutrient Network—SOD1—glaucoma	0.000108	0.0017	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—MTHFR—glaucoma	0.000108	0.00169	CbGpPWpGaD
Gliclazide—Urticaria—Dorzolamide—glaucoma	0.000107	0.000504	CcSEcCtD
Gliclazide—Epistaxis—Timolol—glaucoma	0.000107	0.000503	CcSEcCtD
Gliclazide—Body temperature increased—Dorzolamide—glaucoma	0.000107	0.000501	CcSEcCtD
Gliclazide—Abdominal pain—Dorzolamide—glaucoma	0.000107	0.000501	CcSEcCtD
Gliclazide—Tension—Betaxolol—glaucoma	0.000107	0.000501	CcSEcCtD
Gliclazide—Sinusitis—Timolol—glaucoma	0.000107	0.0005	CcSEcCtD
Gliclazide—Chest pain—Clonidine—glaucoma	0.000106	0.000499	CcSEcCtD
Gliclazide—Arthralgia—Clonidine—glaucoma	0.000106	0.000499	CcSEcCtD
Gliclazide—Abdominal pain—Travoprost—glaucoma	0.000106	0.000499	CcSEcCtD
Gliclazide—Agranulocytosis—Timolol—glaucoma	0.000106	0.000498	CcSEcCtD
Gliclazide—Anxiety—Clonidine—glaucoma	0.000106	0.000497	CcSEcCtD
Gliclazide—Asthenia—Acetazolamide—glaucoma	0.000106	0.000496	CcSEcCtD
Gliclazide—Dizziness—Bimatoprost—glaucoma	0.000106	0.000496	CcSEcCtD
Gliclazide—Nervousness—Betaxolol—glaucoma	0.000106	0.000496	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000106	0.000496	CcSEcCtD
Gliclazide—Urticaria—Brinzolamide—glaucoma	0.000105	0.000495	CcSEcCtD
Gliclazide—Feeling abnormal—Pilocarpine—glaucoma	0.000105	0.000494	CcSEcCtD
Gliclazide—Discomfort—Clonidine—glaucoma	0.000105	0.000493	CcSEcCtD
Gliclazide—Vomiting—Apraclonidine—glaucoma	0.000105	0.000492	CcSEcCtD
Gliclazide—Gastrointestinal pain—Pilocarpine—glaucoma	0.000104	0.00049	CcSEcCtD
Gliclazide—Hypersensitivity—Brimonidine—glaucoma	0.000104	0.000489	CcSEcCtD
Gliclazide—Dry mouth—Clonidine—glaucoma	0.000104	0.000488	CcSEcCtD
Gliclazide—Bradycardia—Timolol—glaucoma	0.000104	0.000487	CcSEcCtD
Gliclazide—Dermatitis—Apraclonidine—glaucoma	0.000104	0.000487	CcSEcCtD
Gliclazide—Headache—Apraclonidine—glaucoma	0.000103	0.000484	CcSEcCtD
Gliclazide—VEGFA—Developmental Biology—PAX6—glaucoma	0.000103	0.00162	CbGpPWpGaD
Gliclazide—Confusional state—Clonidine—glaucoma	0.000103	0.000482	CcSEcCtD
Gliclazide—Rhinitis—Timolol—glaucoma	0.000102	0.00048	CcSEcCtD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—FN1—glaucoma	0.000102	0.0016	CbGpPWpGaD
Gliclazide—Tremor—Betaxolol—glaucoma	0.000102	0.000478	CcSEcCtD
Gliclazide—Asthenia—Brimonidine—glaucoma	0.000101	0.000476	CcSEcCtD
Gliclazide—Infection—Clonidine—glaucoma	0.000101	0.000475	CcSEcCtD
Gliclazide—Body temperature increased—Pilocarpine—glaucoma	0.000101	0.000474	CcSEcCtD
Gliclazide—Abdominal pain—Pilocarpine—glaucoma	0.000101	0.000474	CcSEcCtD
Gliclazide—Ill-defined disorder—Betaxolol—glaucoma	0.000101	0.000473	CcSEcCtD
Gliclazide—Diarrhoea—Acetazolamide—glaucoma	0.000101	0.000473	CcSEcCtD
Gliclazide—Rash—Bimatoprost—glaucoma	0.000101	0.000473	CcSEcCtD
Gliclazide—Dermatitis—Bimatoprost—glaucoma	0.000101	0.000472	CcSEcCtD
Gliclazide—Oedema peripheral—Timolol—glaucoma	0.0001	0.000472	CcSEcCtD
Gliclazide—Anaemia—Betaxolol—glaucoma	0.0001	0.000472	CcSEcCtD
Gliclazide—ALB—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.0001	0.00158	CbGpPWpGaD
Gliclazide—Pruritus—Brimonidine—glaucoma	0.0001	0.00047	CcSEcCtD
Gliclazide—Headache—Bimatoprost—glaucoma	0.0001	0.00047	CcSEcCtD
Gliclazide—Nervous system disorder—Clonidine—glaucoma	9.99e-05	0.000469	CcSEcCtD
Gliclazide—Thrombocytopenia—Clonidine—glaucoma	9.97e-05	0.000468	CcSEcCtD
Gliclazide—VEGFA—Hemostasis—TGFB2—glaucoma	9.95e-05	0.00156	CbGpPWpGaD
Gliclazide—Hypersensitivity—Dorzolamide—glaucoma	9.94e-05	0.000467	CcSEcCtD
Gliclazide—Tachycardia—Clonidine—glaucoma	9.94e-05	0.000467	CcSEcCtD
Gliclazide—Hypersensitivity—Travoprost—glaucoma	9.9e-05	0.000465	CcSEcCtD
Gliclazide—Skin disorder—Clonidine—glaucoma	9.89e-05	0.000465	CcSEcCtD
Gliclazide—Hyperhidrosis—Clonidine—glaucoma	9.85e-05	0.000462	CcSEcCtD
Gliclazide—Visual impairment—Timolol—glaucoma	9.83e-05	0.000461	CcSEcCtD
Gliclazide—Malaise—Betaxolol—glaucoma	9.8e-05	0.00046	CcSEcCtD
Gliclazide—Nausea—Apraclonidine—glaucoma	9.78e-05	0.000459	CcSEcCtD
Gliclazide—Hypersensitivity—Brinzolamide—glaucoma	9.78e-05	0.000459	CcSEcCtD
Gliclazide—Dizziness—Acetazolamide—glaucoma	9.74e-05	0.000457	CcSEcCtD
Gliclazide—Asthenia—Dorzolamide—glaucoma	9.68e-05	0.000455	CcSEcCtD
Gliclazide—Asthenia—Travoprost—glaucoma	9.64e-05	0.000453	CcSEcCtD
Gliclazide—Palpitations—Betaxolol—glaucoma	9.6e-05	0.000451	CcSEcCtD
Gliclazide—Pruritus—Dorzolamide—glaucoma	9.55e-05	0.000448	CcSEcCtD
Gliclazide—Loss of consciousness—Betaxolol—glaucoma	9.55e-05	0.000448	CcSEcCtD
Gliclazide—Eye disorder—Timolol—glaucoma	9.53e-05	0.000447	CcSEcCtD
Gliclazide—Asthenia—Brinzolamide—glaucoma	9.52e-05	0.000447	CcSEcCtD
Gliclazide—Hypotension—Clonidine—glaucoma	9.52e-05	0.000447	CcSEcCtD
Gliclazide—Pruritus—Travoprost—glaucoma	9.51e-05	0.000447	CcSEcCtD
Gliclazide—Tinnitus—Timolol—glaucoma	9.51e-05	0.000446	CcSEcCtD
Gliclazide—Cough—Betaxolol—glaucoma	9.48e-05	0.000445	CcSEcCtD
Gliclazide—Nausea—Bimatoprost—glaucoma	9.48e-05	0.000445	CcSEcCtD
Gliclazide—ABCC8—Metabolism—CA1—glaucoma	9.43e-05	0.00148	CbGpPWpGaD
Gliclazide—Hypersensitivity—Pilocarpine—glaucoma	9.4e-05	0.000441	CcSEcCtD
Gliclazide—Pruritus—Brinzolamide—glaucoma	9.39e-05	0.000441	CcSEcCtD
Gliclazide—Vomiting—Acetazolamide—glaucoma	9.36e-05	0.00044	CcSEcCtD
Gliclazide—Dizziness—Brimonidine—glaucoma	9.35e-05	0.000439	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Clonidine—glaucoma	9.28e-05	0.000436	CcSEcCtD
Gliclazide—Arthralgia—Betaxolol—glaucoma	9.25e-05	0.000434	CcSEcCtD
Gliclazide—Chest pain—Betaxolol—glaucoma	9.25e-05	0.000434	CcSEcCtD
Gliclazide—Myalgia—Betaxolol—glaucoma	9.25e-05	0.000434	CcSEcCtD
Gliclazide—Diarrhoea—Dorzolamide—glaucoma	9.23e-05	0.000434	CcSEcCtD
Gliclazide—Headache—Acetazolamide—glaucoma	9.22e-05	0.000433	CcSEcCtD
Gliclazide—Anxiety—Betaxolol—glaucoma	9.22e-05	0.000433	CcSEcCtD
Gliclazide—Insomnia—Clonidine—glaucoma	9.21e-05	0.000433	CcSEcCtD
Gliclazide—Diarrhoea—Travoprost—glaucoma	9.19e-05	0.000432	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	9.19e-05	0.000431	CcSEcCtD
Gliclazide—Asthenia—Pilocarpine—glaucoma	9.15e-05	0.00043	CcSEcCtD
Gliclazide—KCNJ11—Metabolism—CA1—glaucoma	9.15e-05	0.00144	CbGpPWpGaD
Gliclazide—Paraesthesia—Clonidine—glaucoma	9.15e-05	0.00043	CcSEcCtD
Gliclazide—Discomfort—Betaxolol—glaucoma	9.14e-05	0.000429	CcSEcCtD
Gliclazide—ABCC8—Metabolism—CTSA—glaucoma	9.14e-05	0.00144	CbGpPWpGaD
Gliclazide—Arrhythmia—Timolol—glaucoma	9.11e-05	0.000428	CcSEcCtD
Gliclazide—Dyspnoea—Clonidine—glaucoma	9.08e-05	0.000426	CcSEcCtD
Gliclazide—Diarrhoea—Brinzolamide—glaucoma	9.08e-05	0.000426	CcSEcCtD
Gliclazide—Somnolence—Clonidine—glaucoma	9.05e-05	0.000425	CcSEcCtD
Gliclazide—Dry mouth—Betaxolol—glaucoma	9.05e-05	0.000425	CcSEcCtD
Gliclazide—Pruritus—Pilocarpine—glaucoma	9.02e-05	0.000424	CcSEcCtD
Gliclazide—Confusional state—Betaxolol—glaucoma	8.94e-05	0.00042	CcSEcCtD
Gliclazide—Mental disorder—Timolol—glaucoma	8.93e-05	0.00042	CcSEcCtD
Gliclazide—Dizziness—Dorzolamide—glaucoma	8.93e-05	0.000419	CcSEcCtD
Gliclazide—Rash—Brimonidine—glaucoma	8.91e-05	0.000419	CcSEcCtD
Gliclazide—Dermatitis—Brimonidine—glaucoma	8.9e-05	0.000418	CcSEcCtD
Gliclazide—Dizziness—Travoprost—glaucoma	8.89e-05	0.000417	CcSEcCtD
Gliclazide—Erythema—Timolol—glaucoma	8.88e-05	0.000417	CcSEcCtD
Gliclazide—Malnutrition—Timolol—glaucoma	8.88e-05	0.000417	CcSEcCtD
Gliclazide—KCNJ11—Metabolism—CTSA—glaucoma	8.86e-05	0.00139	CbGpPWpGaD
Gliclazide—Headache—Brimonidine—glaucoma	8.85e-05	0.000416	CcSEcCtD
Gliclazide—Infection—Betaxolol—glaucoma	8.81e-05	0.000414	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Clonidine—glaucoma	8.79e-05	0.000413	CcSEcCtD
Gliclazide—Fatigue—Clonidine—glaucoma	8.78e-05	0.000412	CcSEcCtD
Gliclazide—Dizziness—Brinzolamide—glaucoma	8.77e-05	0.000412	CcSEcCtD
Gliclazide—Nausea—Acetazolamide—glaucoma	8.75e-05	0.000411	CcSEcCtD
Gliclazide—Diarrhoea—Pilocarpine—glaucoma	8.73e-05	0.00041	CcSEcCtD
Gliclazide—Tension—Timolol—glaucoma	8.71e-05	0.000409	CcSEcCtD
Gliclazide—Constipation—Clonidine—glaucoma	8.71e-05	0.000409	CcSEcCtD
Gliclazide—Pain—Clonidine—glaucoma	8.71e-05	0.000409	CcSEcCtD
Gliclazide—Nervous system disorder—Betaxolol—glaucoma	8.7e-05	0.000408	CcSEcCtD
Gliclazide—Thrombocytopenia—Betaxolol—glaucoma	8.68e-05	0.000408	CcSEcCtD
Gliclazide—Tachycardia—Betaxolol—glaucoma	8.65e-05	0.000406	CcSEcCtD
Gliclazide—ABCC8—Metabolism—CA2—glaucoma	8.63e-05	0.00136	CbGpPWpGaD
Gliclazide—Nervousness—Timolol—glaucoma	8.62e-05	0.000405	CcSEcCtD
Gliclazide—Skin disorder—Betaxolol—glaucoma	8.61e-05	0.000404	CcSEcCtD
Gliclazide—Vomiting—Dorzolamide—glaucoma	8.58e-05	0.000403	CcSEcCtD
Gliclazide—Hyperhidrosis—Betaxolol—glaucoma	8.57e-05	0.000403	CcSEcCtD
Gliclazide—ALB—Selenium Micronutrient Network—MTHFR—glaucoma	8.55e-05	0.00134	CbGpPWpGaD
Gliclazide—Rash—Dorzolamide—glaucoma	8.51e-05	0.0004	CcSEcCtD
Gliclazide—Dermatitis—Dorzolamide—glaucoma	8.5e-05	0.000399	CcSEcCtD
Gliclazide—Rash—Travoprost—glaucoma	8.47e-05	0.000398	CcSEcCtD
Gliclazide—Dermatitis—Travoprost—glaucoma	8.47e-05	0.000398	CcSEcCtD
Gliclazide—Headache—Dorzolamide—glaucoma	8.46e-05	0.000397	CcSEcCtD
Gliclazide—Vomiting—Brinzolamide—glaucoma	8.44e-05	0.000396	CcSEcCtD
Gliclazide—Dizziness—Pilocarpine—glaucoma	8.43e-05	0.000396	CcSEcCtD
Gliclazide—Headache—Travoprost—glaucoma	8.42e-05	0.000395	CcSEcCtD
Gliclazide—Nausea—Brimonidine—glaucoma	8.39e-05	0.000394	CcSEcCtD
Gliclazide—Feeling abnormal—Clonidine—glaucoma	8.39e-05	0.000394	CcSEcCtD
Gliclazide—KCNJ11—Metabolism—CA2—glaucoma	8.37e-05	0.00131	CbGpPWpGaD
Gliclazide—Rash—Brinzolamide—glaucoma	8.37e-05	0.000393	CcSEcCtD
Gliclazide—Dermatitis—Brinzolamide—glaucoma	8.36e-05	0.000393	CcSEcCtD
Gliclazide—Gastrointestinal pain—Clonidine—glaucoma	8.33e-05	0.000391	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	8.32e-05	0.00131	CbGpPWpGaD
Gliclazide—Headache—Brinzolamide—glaucoma	8.31e-05	0.00039	CcSEcCtD
Gliclazide—Hypotension—Betaxolol—glaucoma	8.29e-05	0.000389	CcSEcCtD
Gliclazide—Angioedema—Timolol—glaucoma	8.11e-05	0.000381	CcSEcCtD
Gliclazide—Vomiting—Pilocarpine—glaucoma	8.11e-05	0.000381	CcSEcCtD
Gliclazide—ALB—Platelet degranulation—FN1—glaucoma	8.1e-05	0.00127	CbGpPWpGaD
Gliclazide—Urticaria—Clonidine—glaucoma	8.09e-05	0.00038	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Betaxolol—glaucoma	8.08e-05	0.000379	CcSEcCtD
Gliclazide—Abdominal pain—Clonidine—glaucoma	8.05e-05	0.000378	CcSEcCtD
Gliclazide—Body temperature increased—Clonidine—glaucoma	8.05e-05	0.000378	CcSEcCtD
Gliclazide—Rash—Pilocarpine—glaucoma	8.04e-05	0.000378	CcSEcCtD
Gliclazide—Dermatitis—Pilocarpine—glaucoma	8.03e-05	0.000377	CcSEcCtD
Gliclazide—Insomnia—Betaxolol—glaucoma	8.02e-05	0.000377	CcSEcCtD
Gliclazide—Nausea—Dorzolamide—glaucoma	8.02e-05	0.000377	CcSEcCtD
Gliclazide—Headache—Pilocarpine—glaucoma	7.99e-05	0.000375	CcSEcCtD
Gliclazide—Nausea—Travoprost—glaucoma	7.98e-05	0.000375	CcSEcCtD
Gliclazide—CYP2C19—Biological oxidations—GSTT1—glaucoma	7.98e-05	0.00125	CbGpPWpGaD
Gliclazide—Paraesthesia—Betaxolol—glaucoma	7.96e-05	0.000374	CcSEcCtD
Gliclazide—Dyspnoea—Betaxolol—glaucoma	7.9e-05	0.000371	CcSEcCtD
Gliclazide—Nausea—Brinzolamide—glaucoma	7.88e-05	0.00037	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	7.88e-05	0.00124	CbGpPWpGaD
Gliclazide—Palpitations—Timolol—glaucoma	7.84e-05	0.000368	CcSEcCtD
Gliclazide—Dyspepsia—Betaxolol—glaucoma	7.8e-05	0.000367	CcSEcCtD
Gliclazide—Loss of consciousness—Timolol—glaucoma	7.8e-05	0.000366	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—OPN4—glaucoma	7.75e-05	0.00122	CbGpPWpGaD
Gliclazide—Cough—Timolol—glaucoma	7.74e-05	0.000364	CcSEcCtD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	7.72e-05	0.00121	CbGpPWpGaD
Gliclazide—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	7.7e-05	0.00121	CbGpPWpGaD
Gliclazide—Hypertension—Timolol—glaucoma	7.66e-05	0.00036	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Betaxolol—glaucoma	7.65e-05	0.00036	CcSEcCtD
Gliclazide—Fatigue—Betaxolol—glaucoma	7.64e-05	0.000359	CcSEcCtD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC4A4—glaucoma	7.64e-05	0.0012	CbGpPWpGaD
Gliclazide—Constipation—Betaxolol—glaucoma	7.58e-05	0.000356	CcSEcCtD
Gliclazide—Pain—Betaxolol—glaucoma	7.58e-05	0.000356	CcSEcCtD
Gliclazide—Nausea—Pilocarpine—glaucoma	7.58e-05	0.000356	CcSEcCtD
Gliclazide—Arthralgia—Timolol—glaucoma	7.56e-05	0.000355	CcSEcCtD
Gliclazide—Chest pain—Timolol—glaucoma	7.56e-05	0.000355	CcSEcCtD
Gliclazide—Myalgia—Timolol—glaucoma	7.56e-05	0.000355	CcSEcCtD
Gliclazide—VEGFA—Hemostasis—SOD1—glaucoma	7.54e-05	0.00119	CbGpPWpGaD
Gliclazide—Anxiety—Timolol—glaucoma	7.53e-05	0.000354	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	7.5e-05	0.000352	CcSEcCtD
Gliclazide—Hypersensitivity—Clonidine—glaucoma	7.5e-05	0.000352	CcSEcCtD
Gliclazide—Discomfort—Timolol—glaucoma	7.47e-05	0.000351	CcSEcCtD
Gliclazide—Dry mouth—Timolol—glaucoma	7.39e-05	0.000347	CcSEcCtD
Gliclazide—ALB—SLC-mediated transmembrane transport—SLC6A1—glaucoma	7.34e-05	0.00115	CbGpPWpGaD
Gliclazide—Asthenia—Clonidine—glaucoma	7.31e-05	0.000343	CcSEcCtD
Gliclazide—Feeling abnormal—Betaxolol—glaucoma	7.31e-05	0.000343	CcSEcCtD
Gliclazide—Confusional state—Timolol—glaucoma	7.3e-05	0.000343	CcSEcCtD
Gliclazide—CYP2C9—Biological oxidations—GSTT1—glaucoma	7.27e-05	0.00114	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HEYL—glaucoma	7.21e-05	0.00113	CbGpPWpGaD
Gliclazide—Pruritus—Clonidine—glaucoma	7.21e-05	0.000338	CcSEcCtD
Gliclazide—Infection—Timolol—glaucoma	7.2e-05	0.000338	CcSEcCtD
Gliclazide—Nervous system disorder—Timolol—glaucoma	7.1e-05	0.000334	CcSEcCtD
Gliclazide—Urticaria—Betaxolol—glaucoma	7.04e-05	0.000331	CcSEcCtD
Gliclazide—Skin disorder—Timolol—glaucoma	7.04e-05	0.00033	CcSEcCtD
Gliclazide—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	7.02e-05	0.0011	CbGpPWpGaD
Gliclazide—Body temperature increased—Betaxolol—glaucoma	7.01e-05	0.000329	CcSEcCtD
Gliclazide—Hyperhidrosis—Timolol—glaucoma	7e-05	0.000329	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—PTGFR—glaucoma	6.98e-05	0.0011	CbGpPWpGaD
Gliclazide—Diarrhoea—Clonidine—glaucoma	6.97e-05	0.000327	CcSEcCtD
Gliclazide—VEGFA—Cellular responses to stress—CDKN2A—glaucoma	6.87e-05	0.00108	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—TGFB2—glaucoma	6.82e-05	0.00107	CbGpPWpGaD
Gliclazide—Hypotension—Timolol—glaucoma	6.77e-05	0.000318	CcSEcCtD
Gliclazide—Dizziness—Clonidine—glaucoma	6.73e-05	0.000316	CcSEcCtD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.62e-05	0.00104	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—TNF—glaucoma	6.6e-05	0.00104	CbGpPWpGaD
Gliclazide—Musculoskeletal discomfort—Timolol—glaucoma	6.6e-05	0.00031	CcSEcCtD
Gliclazide—Insomnia—Timolol—glaucoma	6.55e-05	0.000308	CcSEcCtD
Gliclazide—Hypersensitivity—Betaxolol—glaucoma	6.53e-05	0.000307	CcSEcCtD
Gliclazide—Paraesthesia—Timolol—glaucoma	6.5e-05	0.000305	CcSEcCtD
Gliclazide—Vomiting—Clonidine—glaucoma	6.48e-05	0.000304	CcSEcCtD
Gliclazide—Dyspnoea—Timolol—glaucoma	6.46e-05	0.000303	CcSEcCtD
Gliclazide—Somnolence—Timolol—glaucoma	6.44e-05	0.000302	CcSEcCtD
Gliclazide—Rash—Clonidine—glaucoma	6.42e-05	0.000302	CcSEcCtD
Gliclazide—Dermatitis—Clonidine—glaucoma	6.42e-05	0.000301	CcSEcCtD
Gliclazide—Headache—Clonidine—glaucoma	6.38e-05	0.0003	CcSEcCtD
Gliclazide—Dyspepsia—Timolol—glaucoma	6.38e-05	0.000299	CcSEcCtD
Gliclazide—Asthenia—Betaxolol—glaucoma	6.36e-05	0.000299	CcSEcCtD
Gliclazide—VEGFA—Axon guidance—MMP2—glaucoma	6.36e-05	0.000999	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—CYP1B1—glaucoma	6.36e-05	0.000999	CbGpPWpGaD
Gliclazide—Pruritus—Betaxolol—glaucoma	6.27e-05	0.000295	CcSEcCtD
Gliclazide—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	6.27e-05	0.000985	CbGpPWpGaD
Gliclazide—Gastrointestinal disorder—Timolol—glaucoma	6.25e-05	0.000294	CcSEcCtD
Gliclazide—Fatigue—Timolol—glaucoma	6.25e-05	0.000293	CcSEcCtD
Gliclazide—ALB—Metabolism—CA5A—glaucoma	6.23e-05	0.000979	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NARFL—glaucoma	6.23e-05	0.000979	CbGpPWpGaD
Gliclazide—Pain—Timolol—glaucoma	6.19e-05	0.000291	CcSEcCtD
Gliclazide—VEGFA—Cellular responses to stress—CDKN1B—glaucoma	6.08e-05	0.000955	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—TXN—glaucoma	6.08e-05	0.000955	CbGpPWpGaD
Gliclazide—Diarrhoea—Betaxolol—glaucoma	6.07e-05	0.000285	CcSEcCtD
Gliclazide—Nausea—Clonidine—glaucoma	6.05e-05	0.000284	CcSEcCtD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—TP53—glaucoma	5.97e-05	0.000939	CbGpPWpGaD
Gliclazide—Feeling abnormal—Timolol—glaucoma	5.97e-05	0.00028	CcSEcCtD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.94e-05	0.000933	CbGpPWpGaD
Gliclazide—Gastrointestinal pain—Timolol—glaucoma	5.92e-05	0.000278	CcSEcCtD
Gliclazide—KCNJ11—Metabolism—TXN—glaucoma	5.9e-05	0.000926	CbGpPWpGaD
Gliclazide—Dizziness—Betaxolol—glaucoma	5.86e-05	0.000275	CcSEcCtD
Gliclazide—CYP2C9—Biological oxidations—CYP1B1—glaucoma	5.8e-05	0.000911	CbGpPWpGaD
Gliclazide—Urticaria—Timolol—glaucoma	5.75e-05	0.00027	CcSEcCtD
Gliclazide—VEGFA—Hemostasis—MMP1—glaucoma	5.75e-05	0.000904	CbGpPWpGaD
Gliclazide—Body temperature increased—Timolol—glaucoma	5.73e-05	0.000269	CcSEcCtD
Gliclazide—Abdominal pain—Timolol—glaucoma	5.73e-05	0.000269	CcSEcCtD
Gliclazide—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	5.72e-05	0.000898	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—TNF—glaucoma	5.7e-05	0.000895	CbGpPWpGaD
Gliclazide—Vomiting—Betaxolol—glaucoma	5.64e-05	0.000265	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	5.61e-05	0.000882	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CA5A—glaucoma	5.59e-05	0.000879	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NARFL—glaucoma	5.59e-05	0.000879	CbGpPWpGaD
Gliclazide—Rash—Betaxolol—glaucoma	5.59e-05	0.000263	CcSEcCtD
Gliclazide—Dermatitis—Betaxolol—glaucoma	5.59e-05	0.000262	CcSEcCtD
Gliclazide—Headache—Betaxolol—glaucoma	5.55e-05	0.000261	CcSEcCtD
Gliclazide—VEGFA—Hemostasis—CAV1—glaucoma	5.52e-05	0.000867	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RPTOR—glaucoma	5.46e-05	0.000858	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—PTGS2—glaucoma	5.46e-05	0.000857	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.41e-05	0.000851	CbGpPWpGaD
Gliclazide—Hypersensitivity—Timolol—glaucoma	5.34e-05	0.000251	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—NCK2—glaucoma	5.29e-05	0.000831	CbGpPWpGaD
Gliclazide—Nausea—Betaxolol—glaucoma	5.27e-05	0.000247	CcSEcCtD
Gliclazide—VEGFA—Hemostasis—FN1—glaucoma	5.25e-05	0.000825	CbGpPWpGaD
Gliclazide—Asthenia—Timolol—glaucoma	5.2e-05	0.000244	CcSEcCtD
Gliclazide—ALB—Platelet activation, signaling and aggregation—SOD1—glaucoma	5.16e-05	0.000811	CbGpPWpGaD
Gliclazide—Pruritus—Timolol—glaucoma	5.12e-05	0.000241	CcSEcCtD
Gliclazide—CYP2C9—Metabolism—NARFL—glaucoma	5.1e-05	0.000801	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CA5A—glaucoma	5.1e-05	0.000801	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC6A13—glaucoma	5.1e-05	0.000801	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—GSTM1—glaucoma	5.08e-05	0.000798	CbGpPWpGaD
Gliclazide—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	5.01e-05	0.000787	CbGpPWpGaD
Gliclazide—Diarrhoea—Timolol—glaucoma	4.96e-05	0.000233	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	4.95e-05	0.000778	CbGpPWpGaD
Gliclazide—Dizziness—Timolol—glaucoma	4.79e-05	0.000225	CcSEcCtD
Gliclazide—VEGFA—Axon guidance—MMP9—glaucoma	4.78e-05	0.000751	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GSTT1—glaucoma	4.71e-05	0.000741	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—VEGFA—glaucoma	4.64e-05	0.000729	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—TNF—glaucoma	4.64e-05	0.000728	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—GSTM1—glaucoma	4.63e-05	0.000728	CbGpPWpGaD
Gliclazide—Vomiting—Timolol—glaucoma	4.61e-05	0.000216	CcSEcCtD
Gliclazide—KCNJ11—Metabolism—GSTT1—glaucoma	4.57e-05	0.000718	CbGpPWpGaD
Gliclazide—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	4.57e-05	0.000718	CbGpPWpGaD
Gliclazide—Rash—Timolol—glaucoma	4.57e-05	0.000215	CcSEcCtD
Gliclazide—Dermatitis—Timolol—glaucoma	4.56e-05	0.000214	CcSEcCtD
Gliclazide—VEGFA—Developmental Biology—MMP2—glaucoma	4.54e-05	0.000713	CbGpPWpGaD
Gliclazide—Headache—Timolol—glaucoma	4.54e-05	0.000213	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—HDAC9—glaucoma	4.5e-05	0.000707	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	4.42e-05	0.000694	CbGpPWpGaD
Gliclazide—Nausea—Timolol—glaucoma	4.3e-05	0.000202	CcSEcCtD
Gliclazide—VEGFA—Hemostasis—NOS3—glaucoma	4.17e-05	0.000655	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—TP53—glaucoma	4.09e-05	0.000642	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—TP53—glaucoma	3.82e-05	0.0006	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CYP1B1—glaucoma	3.76e-05	0.00059	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ABCA1—glaucoma	3.76e-05	0.00059	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.73e-05	0.000586	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—TNF—glaucoma	3.68e-05	0.000579	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ABCA1—glaucoma	3.64e-05	0.000572	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CYP1B1—glaucoma	3.64e-05	0.000572	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—FN1—glaucoma	3.59e-05	0.000565	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SMO—glaucoma	3.52e-05	0.000553	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TGFB2—glaucoma	3.51e-05	0.000552	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—MMP9—glaucoma	3.41e-05	0.000536	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NTRK2—glaucoma	3.22e-05	0.000506	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CA1—glaucoma	3.04e-05	0.000478	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GSTM1—glaucoma	3e-05	0.000472	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CTSA—glaucoma	2.95e-05	0.000463	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GSTM1—glaucoma	2.91e-05	0.000457	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CA2—glaucoma	2.78e-05	0.000437	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NGFR—glaucoma	2.76e-05	0.000434	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CA1—glaucoma	2.73e-05	0.000429	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.72e-05	0.000427	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.72e-05	0.000427	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SOD1—glaucoma	2.66e-05	0.000418	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—MTHFR—glaucoma	2.65e-05	0.000417	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CTSA—glaucoma	2.64e-05	0.000416	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TNF—glaucoma	2.63e-05	0.000412	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NTRK1—glaucoma	2.62e-05	0.000412	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—MTHFR—glaucoma	2.57e-05	0.000404	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CA2—glaucoma	2.5e-05	0.000392	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CA1—glaucoma	2.49e-05	0.000391	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—APOE—glaucoma	2.47e-05	0.000388	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CAV1—glaucoma	2.45e-05	0.000385	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.44e-05	0.000384	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.44e-05	0.000384	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CDKN2B—glaucoma	2.42e-05	0.00038	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CTSA—glaucoma	2.41e-05	0.000379	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—APOE—glaucoma	2.4e-05	0.000376	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CAV1—glaucoma	2.37e-05	0.000373	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—EDN1—glaucoma	2.32e-05	0.000365	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CA2—glaucoma	2.28e-05	0.000358	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TP53—glaucoma	2.27e-05	0.000357	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.23e-05	0.00035	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.23e-05	0.00035	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NGF—glaucoma	2.13e-05	0.000335	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	2.06e-05	0.000323	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—MMP1—glaucoma	2.03e-05	0.000319	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—C3—glaucoma	2.03e-05	0.000319	CbGpPWpGaD
Gliclazide—ALB—Metabolism—TXN—glaucoma	1.96e-05	0.000308	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—CAV1—glaucoma	1.95e-05	0.000306	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—APOE—glaucoma	1.89e-05	0.000297	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CAV1—glaucoma	1.87e-05	0.000294	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—FN1—glaucoma	1.85e-05	0.000291	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—NOS3—glaucoma	1.85e-05	0.000291	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—NOS3—glaucoma	1.79e-05	0.000282	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.79e-05	0.000281	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—FN1—glaucoma	1.78e-05	0.00028	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.77e-05	0.000278	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—TXN—glaucoma	1.76e-05	0.000276	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—BAD—glaucoma	1.76e-05	0.000276	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PTGS2—glaucoma	1.69e-05	0.000266	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PTGS2—glaucoma	1.64e-05	0.000258	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.61e-05	0.000252	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—TXN—glaucoma	1.6e-05	0.000252	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.59e-05	0.00025	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GSTT1—glaucoma	1.52e-05	0.000239	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—NOS3—glaucoma	1.47e-05	0.000231	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.46e-05	0.00023	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.45e-05	0.000228	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NOS3—glaucoma	1.41e-05	0.000222	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GSTT1—glaucoma	1.36e-05	0.000214	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GSTT1—glaucoma	1.24e-05	0.000195	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.23e-05	0.000193	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CDKN1B—glaucoma	1.22e-05	0.000192	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ABCA1—glaucoma	1.21e-05	0.00019	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP1B1—glaucoma	1.21e-05	0.00019	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MMP9—glaucoma	1.13e-05	0.000178	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.1e-05	0.000173	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ABCA1—glaucoma	1.09e-05	0.000171	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP1B1—glaucoma	1.09e-05	0.000171	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—VEGFA—glaucoma	1.06e-05	0.000167	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1e-05	0.000158	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ABCA1—glaucoma	9.91e-06	0.000156	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP1B1—glaucoma	9.91e-06	0.000156	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GSTM1—glaucoma	9.68e-06	0.000152	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GSTM1—glaucoma	8.69e-06	0.000137	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MTHFR—glaucoma	8.56e-06	0.000134	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TP53—glaucoma	8.01e-06	0.000126	CbGpPWpGaD
Gliclazide—ALB—Metabolism—APOE—glaucoma	7.97e-06	0.000125	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GSTM1—glaucoma	7.92e-06	0.000125	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CAV1—glaucoma	7.89e-06	0.000124	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TP53—glaucoma	7.7e-06	0.000121	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MTHFR—glaucoma	7.68e-06	0.000121	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—APOE—glaucoma	7.15e-06	0.000112	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CAV1—glaucoma	7.08e-06	0.000111	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MTHFR—glaucoma	7e-06	0.00011	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—APOE—glaucoma	6.52e-06	0.000102	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CAV1—glaucoma	6.46e-06	0.000101	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NOS3—glaucoma	5.97e-06	9.38e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTGS2—glaucoma	5.46e-06	8.58e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NOS3—glaucoma	5.36e-06	8.42e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTGS2—glaucoma	4.9e-06	7.7e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NOS3—glaucoma	4.88e-06	7.67e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTGS2—glaucoma	4.47e-06	7.02e-05	CbGpPWpGaD
